Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05172934 · ClinicalTrials.gov registry record · Phase 2
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial
A Phase 2 study of Ischemic Stroke, sponsored by ProMedica Health System.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05172934 is a Phase 2 study of Ischemic Stroke that has completed, run by ProMedica Health System. The registered enrollment target is 20 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05172934, a Phase 2 study of Ischemic Stroke, has completed, sponsored by ProMedica Health System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, single center, non-randomized, pilot study to assess the feasibility of IA TNK following standard of care mechanical thrombectomy (MT) in patients with AIS. Participants will receive IA TNK after achieving mTICI 2b or 2c reperfusion with standard of care MT. Patients enrolled into the study will be followed for 3 months after treatment with IA TNK.
Conditions Studied
Interventions
- DRUG intra-arterial tenecteplase
Study Locations (1)
Ohio
- ProMedica Toledo Hospital - Toledo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-03-15 |
| Est. Completion | 2023-11-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05172934
The ClinicalTrials.gov registry entry for NCT05172934 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (99% lower). The listed sponsor is ProMedica Health System, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which intra-arterial tenecteplase is the first listed.
NCT05172934 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05172934 about?
NCT05172934 is a clinical study titled "Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial". Prospective, single center, non-randomized, pilot study to assess the feasibility of IA TNK following standard of care mechanical thrombectomy (MT) in patients with AIS. Participants will receive IA TNK after achieving mTICI 2b or 2c reperfusion with standard of care MT. Patients enrolled into the s...
What is the current status of trial NCT05172934?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2022-03-15. Estimated completion is 2023-11-01.
What conditions does trial NCT05172934 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT05172934?
The interventions under investigation include: intra-arterial tenecteplase (DRUG).
Who is sponsoring clinical trial NCT05172934?
This trial is sponsored by ProMedica Health System, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05172934 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Strategy for Improving Stroke Treatment Response
RECRUITING · Phase 2
-
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
RECRUITING · Phase 2
-
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
RECRUITING · Phase 2
-
Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke
RECRUITING · Phase 2
-
Dietary Nitrate Supplements and Ischemic Stroke Recovery
COMPLETED · Phase 2
-
Mayo Acute Stroke Trial for Enhancing Recovery
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.